Skip to main content
Year archive

4SC AG — 2020 filings

All 14 regulatory filings released by 4SC AG (VSC) in 2020, sourced directly from the official regulator.

14 Filings
2020 Period
2020 filings (14)
Filing Released Lang
Q1 statement / Q1 financial report 2020
Interim / Quarterly Report Q1 2020
2020-05-08 English
4SC provides Q1 2020 update
Earnings Release Q1 2020
2020-04-21 English
Jahresabschluss zum Geschäftsjahr vom 01.01.2019 bis zum 31.12.2019
Annual Report FY 2019
2020-04-21 German
Annual financial report 2019
Annual Report FY 2019
2020-04-17 English
Annual financial report 2019
Annual Report FY 2019
2020-04-17 German
4SC AG: Conference call to be hosted on 21 April 2020 to present the Q1 report 2020
Report Publication Announcement
2020-04-16 English
4SC AG: Bekanntmachung der Einberufung zur Hauptversammlung am 08.05.2020 in Planegg-Martinsried mit dem Ziel der europaweiten Verbreitung gema 121 AktG
AGM Information
2020-04-15 German
4SC AG: FDA Accepts IND Application for MERKLIN 2 Study
Legal Proceedings Report
2020-04-08 English
4SC AG provides results for financial year 2019 and outlook
Earnings Release FY 2019
2020-03-25 English
4SC to present at the World Congress of Cutaneous Lymphomas in Barcelona, Spain
Regulatory Filings
2020-02-12 English
4SC - Resminostat and RESMAIN Study Update
Regulatory Filings
2020-01-31 English
4SC AG: First Patient Enrolled in DONIMI Study Evaluating Domatinostat in the Neoadjuvant Setting in Melanoma
Regulatory Filings
2020-01-15 English
4SC AG: 3 upcoming conferences
Regulatory Filings
2020-01-09 English
4SC AG enters into avelumab supply agreement with Merck KGaA, Darmstadt, Germany and Pfizer for clinical combination study of domatinostat in Merkel cell carcinoma
Regulatory Filings
2020-01-07 English